18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer.
Antonio Avallone,
Luigi Aloj,
Biagio Pecori,
Corradina Caraco,
Alfonso De Stefano,
Fabiana Tatangelo,
Lucrezia Silvestro,
Vincenza Granata,
Francesco Bianco,
Carmela Romano,
Francesca Di Gennaro,
Alfredo Budillon,
Antonella Petrillo,
Paolo Muto,
Gerardo Botti,
Paolo Delrio,
Secondo Lastoria
Oct 18, 2019
There is an unmet need for predictive biomarkers of the clinical benefit of anti-angiogenic drugs.The aim of the present study was to prospectively evaluate the value of FDG-PET/CT performed during and after preoperative...